Cerevance
Develops cell-type-specific therapies and drug targets for patients with neurodegenerative, psychiatric and CNS disorders
Highlights
- New on EvolcAdded 2026-10-30
About Cerevance
Cerevance develops treatments for neurodegenerative, psychiatric and CNS-controlled metabolic disorders. Its NETSseq platform and machine-learning techniques analyze human brain tissue to identify cell-type-specific gene expression profiles and potential drug targets.
The company advances drug candidates for CNS disorders, including solengepras for Parkinson’s disease, and works with pharmaceutical partners on target discovery. It is headquartered in Cambridge, United Kingdom, and was founded in 2016.
Product: Cell-type-specific drug candidates for CNS disorders and the NETSseq platform for identifying therapeutic targets.
Jobs at Cerevance
Leadership
- Craig Thompson · Cheif Executive OfficerSource: company website
- Robert Middlebrook · Cheif Financial OfficerSource: company website
- Johnna Simões · VP, MarketingSource: company website
More biotech & pharma companies
Chemify
Automated chemistry systems that help pharmaceutical and materials partners design and synthesize moleculesNew on EvolcCizzle Biotechnology
Non-invasive blood test for early lung cancer detection based on the CIZ1B biomarker, aimed at healthcare providers and patientsNew on EvolcCNX Therapeutics
Licenses and distributes specialty medicines for CNS and critical care conditions in 60+ marketsNew on EvolcRemote-friendlyConcinnity Genetics
RNA-based control systems that make gene and cell therapies safer, designed for biopharma developersYoung companyNew on EvolcConstructivebio
Designs and manufactures new-to-nature proteins and peptides for pharmaceutical and industrial partnersNew on EvolcCuraleaf International
Medical cannabis cultivation, manufacturing and distribution for patients, clinics and pharmacies in Europe and beyondNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Cloudflare
- Google Analytics 4
- Webflow